PharmaShots | Incisive News in 3 Shots

Subscribe Now

Marginal Zone Lymphoma

$Incyte and MorphoSys Report First Patient Dosing in P-III inMIND Study for Relapsed or Refractory Follicular or Marginal Zone Lymphoma$

Incyte and MorphoSys Report First Patient Dosing in P-III inMIND Study for Relapsed or Refractory Follicular or Marginal Zone Lymp...

April 20, 2021

BioInvent Presents New Clinical and Preclinical Data of BI-1206 at ASH Annual Meeting

BioInvent Presents New Clinical and Preclinical Data of BI-1206 at ASH Annual Meeting

November 5, 2020

Celgene's Revlimid (Lenalidomide) + Rituximab Receive FDA's Approval for Previously Treated Follicular Lymphoma or Marginal Zone Lymphoma in Adults

Celgene's Revlimid (Lenalidomide) + Rituximab Receive FDA's Approval for Previously Treated Follicular Lymphoma or Marginal Zone L...

May 29, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us